Shigatoxin 2 Inhibitors
The chemical class of Shigatoxin 2 inhibitors encompasses a diverse array of antibiotics that target various bacterial processes crucial for the synthesis and production of the toxin. These inhibitors operate through indirect mechanisms, primarily affecting bacterial RNA and DNA synthesis, protein synthesis, and membrane integrity. Rifamycin SV, Polymyxin B, Neomycin, Tetracycline, Novobiocin, Geldanamycin, Streptovaricin, Chloramphenicol, Actinomycin D, Ciprofloxacin, Mitomycin C, and Nalidixic Acid collectively represent a toolbox of potential inhibitors, each disrupting different aspects of the bacterial machinery involved in Shigatoxin 2 expression.
Rifamycin SV and Polymyxin B interfere with bacterial RNA synthesis and membrane integrity, respectively, impacting Shigatoxin 2 indirectly. Antibiotics such as Neomycin and Tetracycline disrupt bacterial protein synthesis, influencing Shigatoxin 2 production through the inhibition of translation machinery. Novobiocin and Geldanamycin target bacterial DNA gyrase and Hsp90, respectively, affecting processes crucial for Shigatoxin 2 synthesis. Additionally, Streptovaricin, Chloramphenicol, Actinomycin D, Ciprofloxacin, Mitomycin C, and Nalidixic Acid further contribute to the repertoire of Shigatoxin 2 inhibitors by disrupting various bacterial processes essential for its expression. This diverse set of inhibitors offers valuable tools for researchers studying Shigatoxin 2 and provides insights into potential strategies for controlling its production by targeting bacterial processes vital for toxin synthesis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rifamycin SV monosodium salt | 14897-39-3 | sc-205839 sc-205839A | 1 g 5 g | $94.00 $307.00 | ||
Rifamycin SV is an antibiotic that inhibits bacterial RNA polymerase, indirectly impacting Shigatoxin 2 by targeting the bacterial machinery required for its expression and production. By interfering with RNA synthesis, Rifamycin SV can limit the production of Shigatoxin 2, providing a potential avenue for controlling its activity. | ||||||
Polymyxin B Sulfate | 1405-20-5 | sc-3544 | 500 mg | $63.00 | 8 | |
Polymyxin B is an antibiotic that disrupts bacterial cell membranes, indirectly inhibiting Shigatoxin 2 by affecting the integrity of the bacterial cell wall. Since Shigatoxin 2 is produced by certain bacteria, Polymyxin B's action on the bacterial membrane can influence the secretion and release of Shigatoxin 2, contributing to its potential inhibition. | ||||||
Neomycin sulfate | 1405-10-3 | sc-3573 sc-3573A | 1 g 5 g | $27.00 $35.00 | 20 | |
Neomycin is an aminoglycoside antibiotic that interferes with bacterial protein synthesis. By targeting the translation machinery in bacteria, Neomycin indirectly impacts the production of Shigatoxin 2, which relies on bacterial protein synthesis for its expression. This antibiotic represents a potential inhibitor by disrupting the bacterial processes necessary for Shigatoxin 2 synthesis. | ||||||
Tetracycline | 60-54-8 | sc-205858 sc-205858A sc-205858B sc-205858C sc-205858D | 10 g 25 g 100 g 500 g 1 kg | $63.00 $94.00 $270.00 $417.00 $634.00 | 6 | |
Tetracycline is a broad-spectrum antibiotic that inhibits bacterial protein synthesis. Similar to Neomycin, Tetracycline indirectly affects Shigatoxin 2 production by disrupting the bacterial translation machinery. This interference with protein synthesis represents a potential strategy for inhibiting Shigatoxin 2, given its dependence on bacterial processes for expression. | ||||||
Novobiocin | 303-81-1 | sc-362034 sc-362034A | 5 mg 25 mg | $128.00 $380.00 | ||
Novobiocin is an antibiotic that inhibits bacterial DNA gyrase, impacting bacterial DNA replication. By interfering with DNA gyrase, Novobiocin indirectly influences the production of Shigatoxin 2, which requires bacterial DNA replication for its synthesis. This antibiotic provides a potential avenue for inhibiting Shigatoxin 2 by disrupting the bacterial processes involved in its expression. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Geldanamycin is an antibiotic that inhibits heat shock protein 90 (Hsp90), a molecular chaperone. Indirectly, Geldanamycin impacts Shigatoxin 2 by affecting the stability and folding of proteins involved in its synthesis. By targeting Hsp90, Geldanamycin represents a potential inhibitor of Shigatoxin 2 through modulation of the chaperone machinery essential for the proper folding and function of proteins involved in its production. | ||||||
Chloramphenicol | 56-75-7 | sc-3594 | 25 g | $90.00 | 10 | |
Chloramphenicol is an antibiotic that inhibits bacterial protein synthesis. Like other protein synthesis inhibitors, Chloramphenicol indirectly influences Shigatoxin 2 production by disrupting the bacterial translation machinery. This interference with protein synthesis provides a potential avenue for inhibiting Shigatoxin 2, as the toxin relies on bacterial processes for its expression and synthesis. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D is an antibiotic that inhibits bacterial and eukaryotic RNA synthesis. By disrupting RNA synthesis, Actinomycin D indirectly impacts Shigatoxin 2 production, which relies on bacterial RNA polymerase for its expression. This antibiotic represents a potential inhibitor by interfering with the bacterial processes necessary for Shigatoxin 2 synthesis. | ||||||
Ciprofloxacin | 85721-33-1 | sc-217900 | 1 g | $43.00 | 8 | |
Ciprofloxacin is an antibiotic that inhibits bacterial DNA gyrase, influencing DNA replication. Indirectly, Ciprofloxacin impacts Shigatoxin 2 production by affecting the stability of bacterial DNA replication. This antibiotic provides a potential avenue for inhibiting Shigatoxin 2 by disrupting the bacterial processes involved in its expression, specifically targeting DNA gyrase and hindering DNA replication essential for the synthesis of the toxin. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Mitomycin C is an antibiotic that forms cross-links in DNA, inhibiting DNA synthesis and function. Indirectly, Mitomycin C influences Shigatoxin 2 production by disrupting bacterial DNA replication. This antibiotic represents a potential inhibitor by interfering with the processes necessary for Shigatoxin 2 synthesis, particularly targeting DNA replication and compromising the integrity of the genetic material essential for the expression of the toxin. | ||||||